Arkuda Therapeutics logo

Arkuda Therapeutics jobs and careers

Cambridge, MA, United States

About Arkuda Therapeutics

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.

Founded in 2018 by Duane Burnett and Gerhard Koenig.

Founded
2018
Employees
11 to 50
Total funding
$108M
Headquarters
Cambridge

Leadership

The top of Arkuda Therapeutics's org chart, with how many people report into each leader.

GKPhoto of Gerhard Koenig

Gerhard Koenig

Co-founder, President & CEO

5 reports

MEPhoto of Mike Esposito

Mike Esposito

Vice President, Finance

1 report

IWPhoto of Irena Webster

Irena Webster

VP, Program Strategy & Dev Ops

JBPhoto of Jean-François Blain

Jean-François Blain

VP, Neurobiology

JLPhoto of Jim Lanter

Jim Lanter

VP, Medicinal Chemistry

Board

BBPhoto of Bruce Booth

Bruce Booth

Chairman, Board of Directors

CD

Christopher O’Donnell

Director

RK

Raymond J. Kelleher

Director